Novartis is a major bio-pharmaceutical company. It lobbies on health-related issues, including Medicare and Medicaid policy, and supports legislation such as H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act. Filings show it spent about $170,000 across five reports and used Corcoran & Associates (Corcoran Partners) as a lobby firm.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
MICHAEL CORCORAN
The latest disclosures for this client.
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
Q2CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
ROBERT BLAIR
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
CARLOS SAN JOSE
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
ESTEBAN BOVO jr
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
Q4CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
Q3CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
Q2CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
Q1CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
RR